Novel Therapies of Breast Cancer

\r\n We mean to bolster the distinguishing proof, pharmacological approval, and interpretation of new sub-atomic growth targets. Also, concentrate on early stage approval of novel disease targets, especially through the advancement and utilization of synthetic tests. To encourage the foundation and upkeep of multidisciplinary joint efforts between Imperial College look into groups; predominately at the Chemistry-Medicine.

\r\n

\r\n  

\r\n

    Related Conference of Novel Therapies of Breast Cancer

    Novel Therapies of Breast Cancer Conference Speakers